We are live on
!
Find out more
Pictet Asset Management Portfolio holdings
AUM
$105B
1-Year Est. Return
38.07%
This Fund
S&P 500
This Quarter
Est. Return
-2.69%
1 Year Est. Return
+38.07%
3 Year Est. Return
+113.98%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$90B
AUM Growth
-$2.64B
(-2.9%)
Cap. Flow
+$2.07B
Cap. Flow
% of AUM
2.3%
Top 10 Holdings %
Top 10 Hldgs %
17.41%
Holding
2,101
New
60
Increased
1,058
Reduced
623
Closed
92
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Synopsys
SNPS
|
+$327M |
| 2 |
Broadcom
AVGO
|
+$315M |
| 3 |
Mastercard
MA
|
+$262M |
| 4 |
Intuit
INTU
|
+$226M |
| 5 |
Digital Realty Trust
DLR
|
+$149M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
+$187M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$169M |
| 3 |
WCN
Waste Connections
WCN
|
+$141M |
| 4 |
NextEra Energy
NEE
|
+$134M |
| 5 |
Cadence Design Systems
CDNS
|
+$127M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.36% |
| 2 | Industrials | 16.63% |
| 3 | Healthcare | 13.3% |
| 4 | Financials | 8.12% |
| 5 | Consumer Discretionary | 7.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CSW
1201
CSW Industrials
CSW
$5.72B
| $713K | ﹤0.01% |
2,447
+63
| +3% | +$20.4K |
|
1202
Inspire Medical Systems
INSP
$1.68B
| $713K | ﹤0.01% |
4,479
+181
| +4% | +$32.7K |
|
1203
ADMA Biologics
ADMA
$2.14B
| $712K | ﹤0.01% |
35,912
+5,027
| +16% | +$86.9K |
|
1204
Tenable Holdings
TENB
$4.16B
| $707K | ﹤0.01% |
20,217
-1,078,493
| -98% | -$42.2M |
|
1205
BILL Holdings
BILL
$4.86B
| $704K | ﹤0.01% |
15,324
+616
| +4% | +$41.4K |
|
1206
Bloom Energy
BE
$72.7B
| $704K | ﹤0.01% |
35,661
-70,358
| -66% | -$1.68M |
|
1207
Piper Sandler
PIPR
$5.41B
| $703K | ﹤0.01% |
11,356
+312
| +3% | +$22.3K |
|
1208
DXC Technology
DXC
$1.73B
| $702K | ﹤0.01% |
41,156
+6,041
| +17% | +$117K |
|
1209
AutoNation
AN
$6.89B
| $701K | ﹤0.01% |
4,338
+384
| +10% | +$68.5K |
|
|
MPT
1210
Medical Properties Trust
MPT
$2.46B
| $699K | ﹤0.01% |
115,974
-56,990
| -33% | -$288K |
|
1211
Assured Guaranty
AGO
$3.35B
| $699K | ﹤0.01% |
7,943
+51
| +0.6% | +$4.57K |
|
1212
NorthWestern Energy
NWE
$4.4B
| $698K | ﹤0.01% |
12,057
+1,357
| +13% | +$73.8K |
|
1213
Vontier
VNT
$4.47B
| $698K | ﹤0.01% |
21,237
+963
| +5% | +$35.1K |
|
1214
COPT Defense Properties
CDP
$4.23B
| $694K | ﹤0.01% |
25,457
-9,948
| -28% | -$280K |
|
1215
UiPath
PATH
$7.9B
| $694K | ﹤0.01% |
67,185
-676
| -1% | -$8.7K |
|
1216
NewMarket
NEU
$8.72B
| $691K | ﹤0.01% |
1,220
+70
| +6% | +$36.9K |
|
1217
CNX Resources
CNX
$5.26B
| $691K | ﹤0.01% |
21,940
+1,154
| +6% | +$34.8K |
|
1218
Asbury Automotive
ABG
$3.76B
| $687K | ﹤0.01% |
3,116
+24
| +0.8% | +$6.26K |
|
1219
Archrock
AROC
$5.93B
| $676K | ﹤0.01% |
25,779
+2,907
| +13% | +$78.4K |
|
1220
Weatherford International
WFRD
$6.54B
| $674K | ﹤0.01% |
12,599
+1,983
| +19% | +$126K |
|
1221
Sensient Technologies
SXT
$5.58B
| $673K | ﹤0.01% |
9,044
-120,109
| -93% | -$8.74M |
|
1222
CNO Financial Group
CNO
$5.07B
| $668K | ﹤0.01% |
16,038
-183
| -1% | -$7.31K |
|
1223
Dycom Industries
DY
$12.4B
| $668K | ﹤0.01% |
4,384
+194
| +5% | +$33.4K |
|
1224
ESCO Technologies
ESE
$7.77B
| $667K | ﹤0.01% |
4,193
+280
| +7% | +$42K |
|
1225
Kratos Defense & Security Solutions
KTOS
$11.9B
| $666K | ﹤0.01% |
22,448
+1,069
| +5% | +$32.4K |
|
Similar funds
Pictet Asset Management's Q1 2025 Portfolio in Review
As of Q1 2025, Pictet Asset Management held 2,101 positions worth $90B, down 2.9% from $92.7B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Pictet Asset Management's Q1 2025 filing shows 60 new, 1,058 increased, 623 reduced and 92 closed positions. Its largest new stake was Verona Pharma: 703,063 shares worth $44.6M. The largest sale was Intra-Cellular Therapies Inc., an estimated $187M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 32% a quarter earlier, followed by Industrials and Healthcare.
- Pictet Asset Management's largest Q1 2025 buy was Verona Pharma: 703,063 shares worth $44.6M.
- Pictet Asset Management added most to Synopsys in Q1 2025, an estimated $327M increase.
- Pictet Asset Management's biggest Q1 2025 reduction was Intra-Cellular Therapies Inc., cutting an estimated $187M.
- Pictet Asset Management fully exited iShares iBoxx $ High Yield Corporate Bond ETF in Q1 2025, selling an estimated $46.5M.
- Pictet Asset Management's ten largest holdings make up 17% of its $90B portfolio in Q1 2025.
- Pictet Asset Management opened 60 new positions and closed 92 in Q1 2025.
- Pictet Asset Management's portfolio value fell 2.9% quarter-over-quarter to $90B.
Based on Pictet Asset Management's 13F filing for Q1 2025, filed 5 May 2025.